Bone Biologics Corp (BBLG) News
Filter BBLG News Items
BBLG News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
BBLG News Highlights
- For BBLG, its 30 day story count is now at 2.
- Over the past 2 days, the trend for BBLG's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest BBLG News From Around the Web
Below are the latest news stories about BONE BIOLOGICS CORP that investors may wish to consider to help them evaluate BBLG as an investment opportunity.
BBLG Announces Split as Pursuit of Breakthrough Treatment ContinuesBy Brad Sorensen, CFA NASDAQ:BBLG READ THE FULL BBLG RESEARCH REPORT There are approximately 350,000 spinal fusion surgeries done in the US every year with varying degrees of success in alleviating often debilitating back pain. The existing dominant technology, known as rhBMP, has been quite successful in advancing the spinal fusion procedure but there are also challenges that can come along with |
Bone Biologics Announces 1-for-8 Reverse Stock SplitBURLINGTON, Mass., December 18, 2023--Bone Biologics Corporation ("Bone Biologics" or the "Company") (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-8. The reverse stock split will take effect as of 12:01 a.m. ET, on Wednesday, December 20, 2023, and shares of Bone Biologics are expected to trade on a post-split basis on Nasdaq under the existing trading symbol, |
Bone Biologics Announces Closing of Registered Direct Offering Priced At-the-Market Under Nasdaq RulesBURLINGTON, Mass., November 20, 2023--Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of an aggregate of 1,139,063 of its shares of common stock at a purchase price of $0.64 per share. In a concurrent private placement, the Company also issued and sold unregistered warrants to purchase up to an aggregate of 1,139,063 |
Dear LI Stock Fans, Mark Your Calendars for Dec. 4Li Auto stock fans are preparing for a major catalyst when the company's shares join the Hang Seng Index starting on Dec. |
Why Is Bone Biologics (BBLG) Stock Down 38% Today?Bone Biologics stock is falling on Friday as shares of BBLG give up some of the gains they saw during an unexpected rally on Thursday! |
Why Is ChargePoint (CHPT) Stock Down 32% Today?ChargePoint stock is falling on Friday as investors in CHPT shares react to preliminary earnings data for the third quarter of the year. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayIt's time to start the final day of trading this week with a breakdown of the biggest pre-market stock movers for Friday morning! |
Why Is Bone Biologics (BBLG) Stock Up 84% Today?Bone Biologics stock is rocketing higher on Thursday with heavy trading of BBLG shares despite a lack of news from the company. |
Why Is Augmedix (AUGX) Stock Down 27% Today?Augmedix stock is taking a beating on Thursday as investors in the company deal with the effects of a public share offering for AUGX. |
Why Is Flora Growth (FLGC) Stock Up 7% Today?Flora Growth stock is rising higher on Thursday as FLGC investors react to the company granting RSAs to certain leaders and board members. |